A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
Keyword(s):
2015 ◽
Vol 149
(4)
◽
pp. 971-980.e1
◽
2019 ◽
Vol 4
(2)
◽
pp. 127-134
◽